Retatrutide 1-gram $1500 White Label
tirzeptide.com

Retatrutide 1-gram $1500 White Label

$1,500.00
{{option.name}}: {{selected_options[option.position]}}
{{value_obj.value}}
Store Logo

Tirzepatide Pharma

View Store

Current Research: Retatrutide is the first triple agonist peptide targeting the Glucagon, GLP-1, and GIP receptors. Retatrutide: It's a novel triple agonist that mimics three hormones: GLP-1, GIP, and glucagon. This combination promotes significant body size reduction, improves blood sugar control, and offers other metabolic benefits. Among its predecessors, Liraglutide (Victoza, Saxenda), Exenatide (Byetta), Semaglutide (Ozempic, Rybelsus, Wegovy), Lixisenatide (Adlyxin), and Dulaglutide ( Trulicity) are GLP-1 receptor agonists; Tirzepatide (Mounjaro) is a GLP-1/GIP dual receptor co-agonist. Survodutide is a Glucagon/GLP-1 dual receptor co-agonist. Quantity: 1-Gram Private label HomeKit contains:  RETATRUTIDE 4 Weeks Supply Per Kit Of 4mg Per Week Each Kit Set Contains: 4 Disposable Subcutaneous Needles 1-Peptide Storage Pen 16mg Of Retatrutide Powder 99.98% Purity 10ml bacteriostatic Water Instruction Booklet Price: $74/kit set for 55,500 kits  Peptide APIs are available in bulk

Show More Show Less

Price History

$459 $4,459 (+$4,000)
$4,459 $2,590 (-$1,869)
$2,590 $1,100 (-$1,490)
$1,100 $1,500 (+$400)
Show Less Show More